Variation of normal protein could be key to resistance to common cancer drug
Sunday, September 7, 2008 - 11:49
in Health & Medicine
Researchers at the Moores Cancer Centre at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient...
Read the whole article on Science Centric
More from Science Centric
Related
- Variation of normal protein could be key to resistance to common cancer drugThu, 28 Aug 2008, 11:15:35 EDT
- 3-drug chemotherapy combination increases organ preservation in patients with larynx cancerTue, 24 Mar 2009, 17:15:35 EDT
- Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer CenterWed, 8 Oct 2008, 3:44:36 EDT
- Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapyThu, 26 Mar 2009, 14:30:30 EDT
- CSHL scientists correlate enzyme expression levels with chemotherapy drug responseFri, 18 Jul 2008, 12:07:44 EDT